Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1237, pseudogene (RNU6-1237P) is a processed pseudogene derived from parental U6 small nuclear RNA gene. U6 snRNA is normally a component of the spliceosome, involved in RNA splicing in eukaryotic cells; however, as a pseudogene, RNU6-1237P does not produce a functional snRNA molecule and is considered transcriptionally inactive or nonfunctional[1][6]. Pseudogenes like this are typically remnants of gene duplication and retrotransposition events and do not serve a role in molecular signaling, cell physiology, or disease, nor are they considered therapeutic targets. Their main significance is as markers of retrotransposition dynamics in the genome and evolutionary history[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1237, pseudogene (RNU6-1237P).